Pharmaceutical company Virupaksha Organics has filed preliminary papers with capital markets regulator Sebi to raise Rs 740 crore through a...

Anlon Healthcare, a Gujarat-based API and pharma intermediates manufacturer, will debut on the stock exchanges on Wednesday after its Rs 12...

Supriya Lifescience aims to double revenue to Rs 1,000 crore by venturing into higher-margin niche segments. Led by Satish Wagh, it is expa...

With Nifty touching a new high, there is a high probability that a large number of investors will be looking at the returns of their portfo...

Revenues rose 33% YoY to Rs 140 crore in Q3FY24. Earnings before interest, taxes, depreciation and amortisation (EBITDA) for Q3FY24 almost ...

Supriya Lifescience, an active pharmaceutical ingredient (API) maker based in Mumbai, aims to double its revenue in the next three years. T...

After a phase of correction the small cap stocks segment has been able once again inch upward. Lower oil prices, softer inflation numbers a...

As broader market indices witness minor consolidation, which normally happens when they are close to all time high as some resistance is bo...

In the two months of the volatile phase with a bearish bias, market breadth has been the biggest casualty. Even in such times during this p...

Supriya Lifescience plunged over 17 per cent after the company said its profits declined 32 per cent sequential

“From among the 60 odd IPOs that were launched, betting on Supriya Life, GR Infra and Devyani International.”

“Our business model is completely derisked and the company has very strong fundamentals. Whatever percentage of growth we have seen in the ...

A day before the IPO, Supriya Lifesciences raised Rs 315 crore from 18 anchor investors, allocating them 1,14,96,351 equity shares for Rs 2...

Active pharmaceutical ingredient (API) manufacturer Supriya Lifescience has a niche basket of 38 APIs across therapeutic segments and it ea...

Investors can bid for a minimum of 54 equity shares and in multiple of 54 thereof. The IPO can be subscribed till December 20, Monday. The ...

The IPO consists of a fresh issue of shares worth Rs 200 crore and an offer of sale (OFS) of shares worth up to Rs 1,000 crore held by its ...

Indian companies in recent years have looked beyond the US-EU-China axis for investments.